Pulmonary artery hypertension is defined as an increased in pulmonary artery pressure exceeding 25 mmHg with normal pulmonary wedge pressure. The pathogenesis of pulmonary artery hypertension involves interaction among vascular, cellular and biomarker components in the pulmonary tissue; with eventual result is elevated pulmonary artery pressure. Vascular components are remodeling of intimal, medial and adventitial layers. Cellular components are played by apoptosis-resistant endothelial cells, proliferative-prone pulmonary artery smooth muscle cells, fibroblasts and inflammatory cells. The functional biomarkers are produced and mediated by these cellular changes, mainly endothelin-1, thromboxane, serotonin, nitric oxide, and prostacyclin. The pulmonary vascular remodeling in pulmonary artery hypertension are diverse and may present in various severity based on underlying etiology. Understanding the shared pathogenesis in pulmonary artery hypertension is of paramount importance in order to improve the disease management and treatment approach.
INTRODUCTION
Pulmonary artery hypertension is considered to be a progressive disease. It is defined as an increased in pulmonary artery pressure exceeding 25 mmHg with normal pulmonary wedge pressure. 1 Pathogenesis of pulmonary artery hypertension is hallmarked by pulmonary vascular remodeling. In addition to structural remodeling from its native vascular cells, perivascular microenvironment played by surrounding cellular components, both from resident cells and migrated cells from remote origin, is supportive in the pathogenesis of pulmonary artery hypertension. 3 These components release cellular products or biomarkers, in response to various stimuli. Release of functional biomarkers, mostly those related to maintenance of pulmonary vascular vasoconstriction and vasodilatation, is predominant. Inflammatory cytokines and chemokines, produced by inflammatory cells, are redundantly increased during development toward pulmonary hypertension. 4 The aim of this review is to discuss the current shared pathogenesis prevailing in pulmonary artery hypertension.
DISCUSSION

Pulmonary Vascular Structural Remodeling
Increased pulmonary artery pressure is mainly due to increased resistance in pulmonary vasculature. In normal condition, pulmonary circulation is a high flow and low pressure circulation. The pulmonary arterioles are the main regulator of pulmonary vascular resistance in a whole. These resistance vessels alter their anatomy and perivascular microenvironment in response to increased intraluminal shear stress. 5 This pathological shear stress triggers abnormal pulmonary vascular tone, which is is mediated by modulation of endothelial-derived relaxing factor and contracting factors. 2 Serotonin transporter (SERT) overexpressed by pulmonary artery smooth muscle cells is responsible for the upregulated mitogenic activity of serotonin by these cells. 8 SERT increased expression enhances serotonin transport into pulmonary smooth muscle cells and induces medial thickening and distal muscularisation. 13 In patients with idiopathic pulmonary artery hypertension, the expression of SERT is increased which is associated with susceptibility to plasma serotonin mitogenic activity. 11 Figure   3 depicted the associated biomarkers and pulmonary vascular remodeling. Part of the review article had been published in its proceedings.
